ATS 2024 Final Program

Click on the session title to view the speakers

131

MONDAY • MAY 20

407 SNAP: Supportive Non-invasive Ventilation for ACS Prevention in Hospitalized Children With Sickle Cell Disease: Perceptions of Patients, Caregivers, and the Health Care Team 408 Initiation of Bi-level Positive Airway Pressure in Children With Sickle Cell Disease for Persistent Hypoxemia: A Retrospective Study 409 The Association of Sleep Disordered Breathing With the Healthcare Utilization in Children With Sickle Cell Disease, A Multicenter Study 410 Sickle Cell Trait Status Increases the Susceptibility to Chlorine Inhalational Injury in Humanized Mouse Model 411 Blood and Bronchoalveolar Lavage Proteomes Identify Correlating Pathways Associated With Allograft Dysfunction in LTx Recipients With Different Underlying Conditions 412 Pediatric Bone Marrow Transplant Patients Demonstrate a High Proportion of Abnormal Baseline Pulmonary Findings: Prospective, Multi-center Results From the Transpire Study 413 Breathing New Life into an Old Problem: Pulmonary Complications After Autologous Hematopoietic Stem Cell Transplant 414 Transpire: Lung Injury in a Longitudinal Cohort of Pediatric Hematopoietic Stem Cell Transplant Patients to Assess Biomakers for Lung Injury 415 Oscillometry Outcomes Before and After Hematopoietic Stem Cell Transplantation (HSCT) 416 Towards Early Detection of Post-Allogeneic Bone Marrow Transplant Bronchiolitis Obliterans Syndrome - The Use of Portable Airway Oscillometry 417 Home Spirometry Is Feasible After Pediatric Hematopoietic Stem Cell Transplant 418 Long-term Trend of Total Lung Capacity in Patients With Fanconi Anemia After Undergoing Hematopoietic Cell Transplantation 419 Single Center Experience in Pediatric Lung Transplant 420 Xenon MRI Detects Pulmonary Gas-exchange Abnormalities in Adult Childhood-cancer Survivors Treated With Bleomycin

421 Success and Feasibility of Multiple Breath

Washout: Prospective Multi-center Results From the Transpire Study

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

B26 UNLOCKING NTM/BRONCHIECTASIS MYSTERIES 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 1A-B (Upper Level) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 201 Validation of the BACES Severity Scoring System in an Australian Cohort of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Patients 202 Developing Steroids As Host Directed Therapy for Non-tuberculous Mycobacterium: Dexamethasone Reduces Pro-inflammatory Responses Induced by Mycobacterium Avium in Human Macrophages Without Diminishing Their Ability to Kill the Mycobacterium 203 The Diagnostic Potential of Serum Anti GPL-core IgA Antibody for MAC Pulmonary Disease Diagnosed by Bronchial Lavage Fluid Culture 204 Body Morphotype in Patients With Pulmonary Nontuberculous Mycobacteria: A Prospective Cohort Study 205 Mycobacterium Avium Complex Treatment Is Associated With Decreased Exacerbation Rate in COPD Patients 206 US Bronchiectasis and NTM Research Registry: Pseudomonas Treatment Patterns in Non-cystic Fibrosis Bronchiectasis Measured by Sociodemographic Factors 207 Factors Influencing Unfavorable Outcomes in Cavitary Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD), With an Emphasis on Imaging Patterns: A Multicenter Cohort Investigation

ATS 2024 Conference Program • San Diego, CA